Adiponectin [150] is “an anti-inflammatory, antiatherogenic adipokine elevated in heart failure (HF) that may protect against endothelial dysfunction by influencing underlying nitric oxide bioavailability.” Because such bioavailability requires BH4, this suggests that adiponectin may act by raising BH4 levels. The gene discussed is ADIPOQ; the disease is heart failure.